Febuxostat: A selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout

Overview of attention for article published in Clinical Therapeutics, November 2009

Altmetric Badge

Mentioned by

patent: 3 patents

Readers on

mendeley: 77 Mendeley

So far, Altmetric has seen 3 patents that reference this research output.

Methods for concomitant treatment of theophylline and febuxostat

Grant US-9107912-B2

United States of America

Methods for treating nephrolithiasis

Grant US-8841333-B2

United States of America

METHODS FOR CONCOMITANT TREATMENT OF THEOPHYLLINE AND FEBUXOSTAT

Application US-20120065236-A1

United States of America

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity.